Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2010 May 26;133(6):1655–1667. doi: 10.1093/brain/awq113

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2010. Published by Oxford University Press on behalf of Brain.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Temporal progression of clinical features and investigations. (A) The times of first appearance of the main clinical features for each patient, up to 120 days after onset of neurological symptoms. (B) The times of all CSF pleocytosis or oligoclonal bands, and all abnormal EEG or MRI findings. Median and interquartile ranges are shown. P-values in B represent Mann–Whitney U-tests for each blue-red pairing. OCB = CSF-specific oligoclonal bands. Percentages (bracketed) show the frequency of each feature or investigation within the total NMDAR-antibody patient cohort.